Finally, another limitation and a possible future research point is the evaluation of the presence of anti-NIS antibodies in other rheumatic and non-rheumatic autoimmune diseases known to be associated with HT, based on a common genetic predisposition [14,85]. The gene discussed is SLC5A5; the disease is hematocrit.